GlassScriptPhysician profile
Steven D Clement
NPI 1407116577
$776.56
in general payments reported to CMS, 2019-2025
20 companies · $91.17 in 2025
The $91.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $16.94 · 2021: $72.37 · 2022: $35.73 · 2023: $151 · 2024: $257 · 2025: $91.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $115.05 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $78.43 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $60.40 | 2022-2023 | Rybelsus, Ozempic, Wegovy |
| Sunovion Pharmaceuticals INC. | $54.75 | 2019-2020 | |
| Amgen INC. | $52.58 | 2019-2025 | Evenity, Prolia |
| Lilly USA, LLC | $49.72 | 2019-2025 | Zepbound |
| Organon LLC | $47.77 | 2023 | Nexplanon |
| Sumitomo Pharma America, INC. | $39.58 | 2024 | Myfembree |
| Myovant Sciences INC. | $32.15 | 2021 | |
| Abbvie INC. | $30.99 | 2021-2024 | |
| Gilead Sciences, INC. | $28.12 | 2019 | |
| Merck Sharp & Dohme LLC | $27.42 | 2025 | Gardasil 9, Capvaxive |
| Almatica Pharma LLC | $26.79 | 2023 | Loreev Xr, Gralise |
| Bioventus LLC | $26.74 | 2021 | |
| Exeltis, USA INC. | $22.45 | 2024 | Slynd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.79 | 2019 | |
| Optinose US, INC. | $18.75 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.56 | 2022 | |
| Exact Sciences Corporation | $14.60 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $13.92 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Clement listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.